期刊文献+

血清半乳甘露聚糖诊断恶性血液病并发侵袭性真菌感染的应用价值 被引量:4

Utility of serum galactomannan in diagnosis of invasive fungal infection in hematologic malignancy
下载PDF
导出
摘要 目的应用半乳甘露聚糖(GM)试剂盒检测恶性血液病并发侵袭性真菌感染(IFI)高危因素患者的血清GM值,评价其对IFI的诊断、疗效预测价值。方法采集83例具有IFI高危因素患者的254份血清,按GM检测试剂盒说明ELISA法检测抗真菌治疗前后GM抗原水平变化。参照IFI分层诊断标准进行评价。结果GM阳性患者36例,其中确诊组3例、临床诊断组5例、拟诊组23例、不符合IFI组5例,阳性率分别为75%、63%、51%和19%;本次GM试验灵敏度0.67,特异度0.81,阳性预测值0.62,阴性预测值0.84;GM阳性患者选择覆盖曲霉的抗生素治疗有效率62%,治疗前、后GM平均值各为1.65±0.85和0.58±0.30,P<0.05;而用氟康唑治疗有效率仅为25%。GM阴性患者采用氟康唑或两性霉素B、伊曲康唑均可,各药物间疗效无明显差别,治疗前、后平均GM值各为0.25±0.10和0.26±0.20,P>0.05。结论GM试验灵敏度中等、特异度较高,高危患者结合临床表现,GM试验检测阳性应立即抗曲霉治疗,动态检测GM值变化可有效判断治疗效果。 Objective To evaluate the value of serum galactomannan (GM) Platelia Aspergillus Kit in the diagnosis and prediction of invasive fungal infection (IFI) in patients with hematologic malignancy. Methods A total of 254 serum samples from 83 high risk patients were collected. ELISA assay was used to analyze the change of GM antigen. Results According to the certainty level of IFI diagnosis, 3, 5, 23 and 5 patients were identified as GM positive in proven, probable, possible and improbable IFI groups respectively. The prevalence of GM in these 4 groups was 75%, 63%, 51% and 19%, respectively. The sensitivity and specificity of galactomannan ELISA assay were 67% and 81 % respectively. The positive and negative predictive values were 62 % and 84 % respectively. The efficacy of amphotericin B or itraconazole in GM-positive patients was superior to that of fluconazole. In GM-negative patients, the efficacy of these three drugs did not show significant difference. After antifungal therapy, the average OD value of GM-positive patients decreased from 1.65 ± 0.85 to 0.58 ± 0.30 (P〈0.05). But in GM negative patients, the value was 0.25 ± 0.10 and 0.26 ± 0.20, respectively (P〉0.05). Conclusions The sensitivity of galactomannan ELISA assay is moderate, but with high specificity. The high risk patients whose GM test is positive should begin antifungal therapy immediately. However, negative result can not exclude IFI. The change of GM values can be considered as a reliable index to predict the antifungal effect.
出处 《中国感染与化疗杂志》 CAS 2009年第2期140-142,共3页 Chinese Journal of Infection and Chemotherapy
基金 广东省科技计划攻关课题(B30202)
关键词 半乳甘露聚糖 血液病 侵袭性真菌感染 galactomannan hematologic malignancy invasive fungal infection
  • 相关文献

参考文献11

  • 1Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis[J]. Mycopathologia, 2007,163(4):191-202.
  • 2Foy PC, van Burik JA, Weisdorf DJ. Galaetomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2007,13(4) :440-443.
  • 3Zedek DC, Miller MB . Use of galaetomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiarycare center over a 12-month period[J]. J Clin Microbiol, 2006,44(4) : 1601.
  • 4血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610. 被引量:248
  • 5Maertens J, Theunissen K, Verbeken E. et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients[J]. Br J Haematol, 2004, 126 (6) ,852-860.
  • 6李军体,孟凡义,孙竞,徐兵,刘晓力.恶性血液病合并侵袭性真菌感染73例治疗分析[J].中国实用内科杂志,2006,26(3):376-378. 被引量:23
  • 7李若瑜.侵袭性真菌感染实验室诊断的现状及展望[J].中华医学杂志,2005,85(21):1449-1450. 被引量:17
  • 8Ascioglu S, Rex JH, de Pauw B,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J]. Clin Infect Dis,2002,34(1);7-14.
  • 9Lim ZY, Ho AY, Devereux S, et al. False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience[J]. J Infect, 2007,55(2) :201-202.
  • 10Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galaetomannan assay:a meta-analysis[J]. Clin Infect Dis, 2006, 42(10):1417-1427.

二级参考文献25

  • 1李若瑜,李东明,余进,刘伟,冀朝辉,王端礼.分子生物学技术在病原真菌鉴定和真菌感染诊断中的应用[J].北京大学学报(医学版),2004,36(5):536-539. 被引量:13
  • 2黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 3王景枝,刘代红,许兰平,陈欢,刘开彦,黄晓军.伊曲康唑在异基因造血干细胞移植患者真菌感染中的应用[J].中华内科杂志,2007,46(1):29-31. 被引量:7
  • 4Richardson MD,Jones BL.Therapeutic Guidelines in systemic fungal Infections. 3rd ed.Current Medical Literature,2003.
  • 5Pfaller MA, McGinnis MR. The laboratory and clinical mycology. In: Anaissie EJ, McGinnis MR,Pfaller MA, eds. Clinical Mycology. Philadelphia: Churchill Livingstone, 2003.
  • 6Challier S, Boyer S, Abachin E, et al.Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol, 2004, 42:844-846.
  • 7Edmond MB,Wallace SE,McClish DK,et al.Nosocomial bloodstream infections in United States hospitals:a three-year analysis[J].Clin Infect,1999,29 (2):239-244.
  • 8Bodey G,Bueltmann B,Duguid W,et al.Fungal infections in cancer patients:an international autopsy survey[J].Eur J Clin Microbiol Infect Dis,1992,11 (2):99 -109.
  • 9Pfaller MA,Messer SA,Hollis RJ,et al.Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States[J].Diagn Microbiol Infect Dis,1999,33 (4):217-222.
  • 10Morgan J,Wannemuehler KA,Marr KA,et al.Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation:interim results of a prospective multicenter surveillance program.Med Mycol,2005,43 Suppl 1:S49-58.

共引文献291

同被引文献44

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部